Lobbying & Influence

Work on Capitol Hill? Enjoy free access.

SIGN IN | SUBSCRIBE

After PhRMA, Tauzin Likely to Start New Firm

By Matthew Murray
Roll Call Staff
June 23, 2010, Midnight

The sun is setting on a K Street bromance.
Next Wednesday, former Rep. Billy Tauzin (R-La.) will turn the lights off in his cavernous Chinatown office at the Pharmaceutical Research and Manufacturers of America for the last time. But for the first time in 18 years, his trusty mouthpiece Ken Johnson won’t be at his side.

Take It Off 3:54 p.m.
Study: Most Tariff Bills Would Count as ‘Earmarks’ 3:38 p.m.
Senate Ethics Panel Admonishes Tom Coburn Over Contact With Ensign Aide 2:28 p.m.
Hill Vet Smokes BBQ Competitors 2:06 p.m.
The Sexy Real Estate Edition 1:30 p.m.
Eric Cantor Announces GOP Summer Agenda
Liberals Balk at Nancy Pelosi Tax Proposal

LATEST NEWS

MOST POPULAR

MOST EMAILED

HOH: Take It Off 3:54 p.m.
Study: Most Tariff Bills Would Count as ‘Earmarks’ 3:38 p.m.
Senate Ethics Panel Admonishes Tom Coburn Over Contact With Ensign Aide 2:28 p.m.
HOH: Hill Vet Smokes BBQ Competitors 2:06 p.m.
HOH: The Sexy Real Estate Edition 1:30 p.m.
Eric Cantor Announces GOP Summer Agenda

Slideshow |

May 24, 2012

Back

Play/Pause

Forward

Slideshow Image

Sen. Scott Brown arrives in the Capitol via the Senate subway for votes on the Food and Drug Administration reauthorization bill on Thursday.

See More Multimedia

Email Newsletter Sign-Up

Breaking News Alerts
Morning and Afternoon Headlines
Heard on the Hill Updates

Follow Roll Call:

iphone image

YouTube

Defense Sequester Policy Briefing

Defense Sequester Policy Briefing

Nobody seems to like the automatic Pentagon spending cuts set for January, but there is little Congressional agreement on an alternative.